VentriPoint Diagnostics Ltd (VPT) - Cash Flow Conversion Efficiency
Based on the latest financial reports, VentriPoint Diagnostics Ltd (VPT) has a cash flow conversion efficiency ratio of 0.021x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-95.70K ≈ $-69.23K USD) by net assets (CA$-4.66 Million ≈ $-3.37 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See VentriPoint Diagnostics Ltd (VPT) net asset quality to measure how much of total assets are equity-financed.
VentriPoint Diagnostics Ltd - Cash Flow Conversion Efficiency Trend (2005–2024)
This chart illustrates how VentriPoint Diagnostics Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check VentriPoint Diagnostics Ltd (VPT) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
VentriPoint Diagnostics Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of VentriPoint Diagnostics Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Kresna Graha Investama Tbk PT
JK:KREN
|
0.008x |
|
CTRL Group Limited Ordinary Shares
NASDAQ:MCTR
|
-0.546x |
|
Panca Global Securities Tbk
JK:PEGE
|
-0.129x |
|
Vichitbhan Palmoil Public Company Limited
BK:VPO
|
-0.267x |
|
Lena Lighting S.A.
WAR:LEN
|
-0.024x |
|
Cassius Mining Ltd
AU:CMD
|
-0.253x |
|
Minox International Group Berhad
KLSE:0288
|
0.026x |
|
Volution Group plc
LSE:FAN
|
0.147x |
Annual Cash Flow Conversion Efficiency for VentriPoint Diagnostics Ltd (2005–2024)
The table below shows the annual cash flow conversion efficiency of VentriPoint Diagnostics Ltd from 2005 to 2024. For the full company profile with market capitalisation and key ratios, see VentriPoint Diagnostics Ltd (VPT) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CA$-2.98 Million ≈ $-2.16 Million |
CA$-3.39 Million ≈ $-2.45 Million |
1.136x | +105.66% |
| 2023-12-31 | CA$189.71K ≈ $137.23K |
CA$-3.80 Million ≈ $-2.75 Million |
-20.052x | -2107.17% |
| 2022-12-31 | CA$4.55 Million ≈ $3.29 Million |
CA$-4.14 Million ≈ $-2.99 Million |
-0.908x | -140.60% |
| 2021-12-31 | CA$8.33 Million ≈ $6.03 Million |
CA$-3.15 Million ≈ $-2.28 Million |
-0.378x | -180.59% |
| 2020-12-31 | CA$-2.35 Million ≈ $-1.70 Million |
CA$-1.10 Million ≈ $-795.98K |
0.469x | -51.41% |
| 2019-12-31 | CA$-2.47 Million ≈ $-1.79 Million |
CA$-2.38 Million ≈ $-1.72 Million |
0.964x | -69.22% |
| 2018-12-31 | CA$-973.26K ≈ $-704.04K |
CA$-3.05 Million ≈ $-2.21 Million |
3.133x | +65.95% |
| 2017-12-31 | CA$-1.63 Million ≈ $-1.18 Million |
CA$-3.07 Million ≈ $-2.22 Million |
1.888x | +93.11% |
| 2016-12-31 | CA$-2.25 Million ≈ $-1.63 Million |
CA$-2.20 Million ≈ $-1.59 Million |
0.978x | -83.62% |
| 2015-12-31 | CA$-269.66K ≈ $-195.07K |
CA$-1.61 Million ≈ $-1.16 Million |
5.967x | +1033.35% |
| 2014-12-31 | CA$-2.40 Million ≈ $-1.73 Million |
CA$-1.26 Million ≈ $-912.31K |
0.526x | -36.40% |
| 2013-12-31 | CA$-3.12 Million ≈ $-2.26 Million |
CA$-2.58 Million ≈ $-1.87 Million |
0.828x | -49.84% |
| 2012-12-31 | CA$-2.65 Million ≈ $-1.92 Million |
CA$-4.37 Million ≈ $-3.16 Million |
1.650x | -3.38% |
| 2011-12-31 | CA$-2.33 Million ≈ $-1.68 Million |
CA$-3.98 Million ≈ $-2.88 Million |
1.708x | -27.65% |
| 2010-12-31 | CA$-860.17K ≈ $-622.24K |
CA$-2.03 Million ≈ $-1.47 Million |
2.360x | +434.52% |
| 2009-12-31 | CA$-3.26 Million ≈ $-2.36 Million |
CA$-1.44 Million ≈ $-1.04 Million |
0.442x | -80.32% |
| 2008-12-31 | CA$-1.87 Million ≈ $-1.35 Million |
CA$-4.20 Million ≈ $-3.04 Million |
2.244x | +682.50% |
| 2007-12-31 | CA$2.50 Million ≈ $1.81 Million |
CA$-965.08K ≈ $-698.12K |
-0.385x | -590.65% |
| 2006-12-31 | CA$670.44K ≈ $484.98K |
CA$-37.40K ≈ $-27.06K |
-0.056x | -886.77% |
| 2005-12-31 | CA$695.36K ≈ $503.01K |
CA$-3.93K ≈ $-2.84K |
-0.006x | -- |
About VentriPoint Diagnostics Ltd
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers. It also provid… Read more